Our understanding of the physiology and pathology of the adrenal cortex has increased greatly in recent years (Bayliss, I953, I955; Prunty, I956) and it is now possible to treat many of its disorders rationally, safely and effectively.
Classification of Adrenal Cortical Disorders
Lesions of the adrenals frequently cause disturbance of endocrine function. Various clinical syndromes may result, depending on whether the secretion is increased or diminished and, when it is increased, which hormones predominate. (ii) Carcinoma. (iii) Rare tumours, cysts, etc.
Cushing's Syndrome
This rather uncommon condition is caused in most cases by excessive secretion of adrenocortical hormones. This may be due either to an abnormality in the adrenals themselves or to an excessive production of corticotrophin (ACTH) by the anterior pituitary gland. It is often impossible to tell whether the adrenal or the pituitary is primarily at fault. An identical clinical picture may be produced by the prolonged therapeutic administration of cortisone (and its analogues) or corticotrophin. CAUSATIVE LESIONS (i) Adrenal. The adrenal glands may be (I) large (hyperplastic), (2) structurally normal, but with biochemical evidence of hyperfunction, or (3) the site of a tumour (adenoma or carcinoma) . A tumour is the commonest finding in children, while large or normal glands are commoner in adults. Tumours are nearly always malignant in men, but often benign in women.
(ii) Pituitary. Occasionally the anterior pituitary gland is the seat of a basophil tumour, which secretes corticotrophin and stimulates the adrenal cortex. These tumours are nearly always small and do not cause pressure effects. The terms ' Cushing's disease' or' pituitary basophilism ' are applied to such cases. In others there may possibly be a functional disorder of the pituitary which results in excessive secretion of corticotrophin.
(iii) Other Causes. Cushing's syndrome is rarely associated with lesions of the hypothalamus, ovaries or liver or with carcinoma of the bronchus, thymus or pancreas (Thorne, 1952) . CLINICAL FEATURES (Fig. i) affected much more commonly than men. The clinical and metabolic features (Cushing, at the same time (Steinbach et al., 1952) . This procedure will demonstrate gross hyperplasia and many tumours, but there is a large margin of error. TREATMENT The grave prognosis makes early treatment essential. Hypokalaemic alkalosis should be corrected by potassium chloride and infections must be controlled with antibiotics. If an adrenal tumour can be located it should be removed. In most cases, however, full investigation leaves doubt about the nature of the lesion, and surgical exploration of the adrenals is necessary. When the syndrome is caused by hyperplastic or hyperfunctioning glands adrenalectomy at present provides the best prospect of relief, although effective adrenocortical antagonists may one day render surgery unnecessary (Thorn et al., 1956) .
Irradiation of the pituitary (Skrimshire, I955) and hypophysectomy are less satisfactory procedures and should be reserved for those very rare cases in which a pituitary tumour can be demonstrated.
The only point at issue is whether the adrenal resection should be sub-total or total. Sub-total removal produces a clinical remission in all cases and most of the patients require no cortisone replacement therapy after the first few months. A few, however, relapse later and require a further operation for removal of the remaining portion of gland. The effects of total adrenalectomy are probably more lasting, but permanent cortisone replacement is necessary and life is relatively precarious. Unless future experience shows that relapses are common, removal of nine-tenths of one gland and all of the other would seem to be the procedure of choice (Sprague et al., I953; Beck et al., 1954) .
If no tumour has been located before operation the left gland is explored first, since it is the more accessible and the easier to resect sub-totally. When it has been exposed three courses are possible (Priestley et (Taylor, I953) . In Cushing's syndrome, where gross obesity is often a complicating factor, it is best to operate on each gland separately and to use a postero-lateral incision with the patient in the lateral position.
On the left side the iith rib is resected extrapleurally and the gland identified by its orange colour (which is quite different from that of the surrounding fat or of the tail of the pancreas) at the upper pole of the kidney. The lateral and anterior aspects are cleared without disturbing the gland posteriorly or injuring the small vessels which enter its periphery, and a small cornernot more than one-tenth of the whole-is selected to be left in the body. The upper pole is usually suitable and is severed from the main portion of the gland with scissors (Fig. 2) if the cortisone dosage is reduced too rapidly after operation or if, as a result of stress, the patient's cortisone requirements increase. The first symptoms are early morning anorexia and nausea, aggravated by ambulation and eased by rest. The nausea becomes persistent and is followed by vomiting and dehydration. There is bodily weakness and a feeling of uneasiness or actual pain in the abdomen. The signs are tachycardia, an irregular low-grade fever and marked desquamation of the facial skin, followed later by hypotension, which may cause oliguria and anuria. Sometimes there are mental changes. The condition, which may be fatal if it is not treated, responds at once to an increase in the dose of cortisone or, if there is vomiting, to hydrocortisone given intravenously.
RESULTS OF SURGICAL THiERAPY
The immediate post-operative period may cause anxiety, but with proper care the operative mortality is low (one death in a personal series of I3 cases). Within a few weeks the appearance starts to return towards normal and the process is usually complete within about six months (Figs.  3 and 4) . The skin of the face, and sometimes of the body, undergoes a fine scaly desquamation with itching, and this is accentuated if adrenal deficiency develops. Weight is lost, strength and energy are regained and a normal bodily configuration returns. Signs of virilism diminish, but rarely disappear completely. The hair becomes lighter and softer and sexual function is restored. (Sterility persists after destruction or removal of the pituitary.) The bones become re-calcified rather slowly and backache may persist longer than the other symptoms. Spinal deformities become stabilized. Brown pigmentation of the Addisonian type often develops temporarily in the operation scars and sometimes elsewhere. The blood pressure (both systolic and diastolic) falls significantly in all but returns to normal in only a few. The Adreno-Genital Syndrome The adreno-genital syndrome (Broster, I939; Simpson, I953) is a rare condition, which may be caused by a tumour or by hyperplasia of the adrenal cortex. The essential lesion in hyperplasia is probably biochemical and consists of a failure to synthesize hydrocortisone, excessive amounts of its precursor, I7-hydroxyprogesterone, being produced instead (Brit. med. J., I955).
This substance is androgenic and, unlike hydrocortisone, does not inhibit the production of corticotrophin by the pituitary. Consequently, there is hypersecretion of corticotrophin, hyperplasia of the adrenal cortex (affecting mainly the zona reticularis), excessive production of 17-hydroxyprogesterone and other androgens and deficiency of glucocorticoids.
The adrenal androgens, which are formed in neoplastic or hyperplastic glands, are responsible for the main clinical features of the syndrome. In some patients, especially those with tumours, there is an excess of glucocorticoids and these may cause some features of Cushing's syndrome. 
CLINICAL FEATURES
The clinical picture varies with the age and sex of the patient, and the table above shows the main varieties:-The androgens have three main effects: i. Virilization (hirsutism, deeping of the voice, muscular development, increased libido and hypertrophy of the clitoris) (Fig. 5) .
2. Regression of female characteristics (amenorrhoea, sterility, atrophy of the breasts, loss of subcutaneous fat and atrophy of the external genitalia (except the clitoris)).
3. Non-specific actions (protein synthesis, increase in weight, acne and occasionally fluid and salt retention and hypertension). In children there is also precocious bodily growth and premature appearance and fusion of the epiphyses. The testes and prostate do not develop abnormally since there is no increased production of pituitary gonadotrophins. In the foetus the urogenital sinus may fail to differentiate into its urethral and lower vaginal components and at birth a female child may be mistaken for a male (Wilkins et 
DIAGNOSIS
The 17-ketosteroid excretion, which is nearly always raised, can be suppressed by cortisone in benign lesions, but not in carcinoma. In hyperplasia pregnanetriol (a metabolite of I7-hydroxyprogesterone) is found constantly in the urine, and in carcinoma there is often an excess of the androgen dehydroisonadrosterone. Radiographs of the adrenals may reveal hyperplasia or tumour. In female pseudo-hermaphrodites endoscopy will reveal the presence of a uterine cervix and skin biopsy will determine the ' chromosomal sex.' TREATMENT The treatment depends on the nature of the adrenal lesion. A tumour requires surgical removal, while hyperplasia is treated with cortisone, which inhibits the production of corticotrophin and supplies glucocorticoid (Wilkins et al., I955a) .
Resection of hyperplastic adrenal tissue has yielded variable results in the past (Broster et al., 1953) , but has now been largely abandoned. If the presence of a tumour cannot be excluded after full investigation, two courses are possible. If the condition is long-standing, a trial of cortisone therapy may be given for a few months. If the onset has been rapid, surgical exploration should be undertaken.
The results of treatment by removal of a tumour or by cortisone suppression depend on the age and development of the patient when treatment is started (Wilkins et 
Feminization in the Male
This excessively rare syndrome is caused by an oestrogen-secreting carcinoma and the usual presenting feature is gynaecomastia. The tumour should be removed if possible (Wilkins, 1948) .
Primary Hyperaldosteronism (Conn's Syndrome) This rare condition, which has been recognized only recently, is caused by an adrenocortical adenoma, or occasionally carcinoma, which probably excretes excessive amounts of the electrocorticoid aldosterone (Conn, 1955; Lancet, 1956 suffering from 'manic psychosis' but settled down on treatment and was discharged within a few months. There was no record of any abdominal or thoracic lesion or symptoms, and no history of difficulty in taking food or swallowing. For the past ten years or so he has had no difficulty in eating or drinking, his appetite has been good, and his bowel habit reasonably normal. He was admitted to hospital for investigation and Fig. 2 shows the result of a barium swallow. Fig. 3 is an oblique view. Oesophagoscopy revealed no ulceration of the oesophageal wall. During his short stay in hospital, he remained afebrile, had no complaints, and appeared to eat and drink quite normally.
Comment
This case is chiefly of interest because of the radiological appearances in the P.A. view of chest. Shanks, discussing this condition in its latter stages, states that a straight film of the chest may show an opacity emerging from the superior mediastinum spreading over and obscuring the right hilum to disappear behind the right border of the heart. In this case, the opacity continues practically in a straight line from the clavicle to the extreme base, and well to the right of the heart shadow. Ritvo shows a similar picture but observes that the extent of the change is not typical of cardiospasm. In the present case, the condition has undoubtedly been progressing for at least 36 years. There is no obstruction to the passage of food into the stomach, and there would appear to be no indications for surgical treatment.
